Searchable abstracts of presentations at key conferences in endocrinology

ea0090p26 | Calcium and Bone | ECE2023

Long-term trajectories of bone metabolism parameters and bone mineral density (BMD) in obese patients treated with metabolic surgery: a real-world, retrospective study

Greco Carla , Passerini Francesca , Coluccia Silvia , Teglio Marta , Bondi Mario , Mecheri Fouzia , Trapani Vincenzo , Volpe Alessandro , Toschi Patrizia , Madeo Bruno , Simoni Manuela , Rochira Vincenzo , Santi Daniele

Background and Aim: Potential adverse effects of metabolic surgery on skeletal integrity remains an important concern. Bone loss is common after surgery due to multiple factors including vitamin D deficiency, altered calcium metabolism, mechanical load reduction and hormonal pattern changes. It is still not clear if the effects on bone health and calcium homeostasis vary according to each surgical technique. Further, long-term data of different surgical approaches are poor. Th...

ea0077pl7 | Clinical Endocrinology Trust Lecture | SFEBES2021

The yin and yang of hormones and glucose

Korbonits Marta

The balanced hormonal regulation of metabolism is the cornerstone of endocrinology. One of the most elegant aspects of our discipline is that increased or decreased hormone activities lead to predictable changes and diseases. We were surprised, therefore, to identify a novel disease where the same genetic alteration, a missense change in the beta-cell transcription factor MAFA, causes two very opposite conditions: life-threatening hypoglycaemia due to numerous small i...

ea0081s21.1 | Autoimmune polyendocrine syndromes | ECE2022

Autoimmunity in families with Addison’s disease

Fichna Marta

Since individuals with autoimmune Addison’s disease (AD) present considerable co-occurrence of other autoimmune conditions, clustering of autoimmunity was also predicted among their relatives. We aimed to evaluate the burden of autoimmunity in families of patients with AD by means of a survey, serum autoantibody testing and correlating these data with the established genetic risk factors (PTPN22 rs2476601, CTLA4 rs231775, and BACH2 rs3757247). 7...

ea0090pl4 | The curious case of pituitary tumours | ECE2023

The curious case of pituitary tumours

Korbonits Marta

While just a few years ago we rarely thought about genetics when looking after patients with pituitary tumours, now this aspect of endocrinology, similar to many others, is keeping the genetic labs increasingly busy. Understanding the molecular mechanisms involved in pituitary tumorigenesis and discovering the importance of the microenvironment of these tumours led to deeper understanding of pituitary tumorigenesis. Applying these new discoveries to predict tumour behaviour an...

ea0040l16 | AIP and the somatostatin signalling in pituitary tumours | ESEBEC2016

AIP and the somatostatin signalling in pituitary tumours

Korbonits Marta

Germline mutations in the AIP gene predispose to the development of pituitary adenomas, most often GH secreting tumours. These patients often poorly respond to medical therapy with somatostatin analogues.There are two mechanisms suggested to be involved in this poor response.One suggests that the somatostatin-induced upregulation of the tumour suppressor gene Zac1 involves AIP. SSTR2 agonist treatment leads to AIP...

ea0059mte1 | What the endocrinologist needs to know about genetics | SFEBES2018

What the endocrinologist needs to know about genetics?

Korbonits Marta

Prevention of disease or severe complications is the intended hallmark of modern medicine. Currently available diagnostic methods allow the early recognition of an increasing number of diseases allowing timely treatment and hopefully better long-term outcomes. The best examples of this strategy are genetic diseases and every week the genetic cause for another disease is identified. Therefore, the understanding of the practicing clinician the nature and pitfalls of genetic test...

ea0031pl6 | Society for Endocrinology Medal Lecture | SFEBES2013

Genes and giants

Korbonits Marta

The number of diseases associated with genetic abnormalities has grown exponentially in the last decade. Pituitary tumours are no exception, as now at least nine genes are known to predispose to pituitary tumour development: MEN1, PRKAR1A, AIP, CDKN1B, SDH (A, B, C and D) and DICER1. On the other hand, only a small minority of the pituitary-related gene carriers develop pituitary disease, suggesting that other interfering genes or factors are also important. ...

ea0031pl6biog | Society for Endocrinology Medal Lecture | SFEBES2013

Society for Endocrinology Medal Lecture

Korbonits Marta

Professor Korbonits is a clinical academic endocrinologist with special interest in pituitary tumorigenesis and as well as metabolic effects of hormones. She graduated in medicine at Semmelweis Medical School in Budapest and works in the Department of Endocrinology at Barts and the London School of Medicine at St. Bartholomew’s Hospital in London since 1991, where currently she is Co-Centre Head. She received and MD and a PhD from the University of London and was a recipi...

ea0026s8.1 | The biological clock and metabolism | ECE2011

Clock genes in human adipose tissue

Garaulet Marta

Circadian rhythms are such an innate part of our lives that we rarely pause to speculate why they even exist. Some studies have suggested that the disruption of the circadian system may be causal for obesity and manifestations of metabolic syndrome (MetS). Shift-work, sleep-deprivation and bright-light-exposure at night are related to increased adiposity (obesity) and prevalence of MetS. It has been provided evidence of clock genes expression in human adipose tissue and demons...